A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients

Clinical trial NCT01284920 · COMPLETED

Trial details

NCT number: NCT01284920
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Neoplasms Castration Resistant Prostate Cancer (CRPC)

Start date: 2010-11-02
Primary completion: 2012-07-12
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.